SEC Form D private-offering filing

Pheast Therapeutics, Inc.

Name: Pheast Therapeutics, Inc. - new SEC Form D private-offering filing, Redwood City, CA
Published: 2025-10-16

A new SEC Form D private-offering notice from Redwood City, CA, a $39,999,993 filer-stated offering target in Biotech. The source filing is one click away.

Pheast Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical stage immuno oncology biotech developing macrophage checkpoint inhibitor therapies for cancer, spun out of Stanford University

Filed 2025-10-16Filed to raise $39,999,993First money in 2025-10-07Raised so far $24,588,083HQ (as filed) Redwood City, CASector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified pheast.com↗Named in the filing 7 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.